Delivery Order SPE2DB25D3404-SPE2DB25FUPAE
Award Date 6/26/25
Potential Completion Date 7/18/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $13,953.30 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of LEQVIO 284 mg/1.5 mL syringes. The contract, which is non-set-aside and competitively awarded, carries an ultimate completion date of September 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of LEQVIO 284 mg/1.5 mL syringes with a ceiling value of $27,906.60. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 30, 2025. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 18, 2025, by the Defense Logistics Agency (DLA) for the supply of LEQVIO 284 mg/1.5 mL syringes with a ceiling value of $16,278.85. This firm fixed-price delivery order, which is scheduled for completion by July 11, 2025, is unset-aside and competitively awarded. The award represents a continuation of the company's substantial role as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of LEQVIO 284 mg/1.5 ml syringes, with a contract value of $2,325.55 and an ultimate completion date of July 11, 2025. This is a firm fixed-price delivery order issued without a set-aside designation, reflecting a competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award is a...
- The U.S. Department of Defense's Medical Supply Chain awarded a $4,651.10 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of LEQVIO 284 mg/1.5 ml syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by October 17, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the company's proven capability to compete in...
- This delivery order, awarded August 4, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides LEQVIO 284 mg/1.5 mL syringes valued at $9.3K with a completion date of August 25, 2025. The contract utilizes firm fixed pricing with no set-aside designation, reflecting open and competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a $34,883.25 delivery order to AmerisourceBergen Drug Corp for the supply of LEQVIO 284 mg/1.5 mL syringes. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 14, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of LEQVIO 284 MG/1.5 ML syringes. This $4,394.82 delivery order is part of a larger $999,999,999.00 indefinite delivery contract awarded solely to Amerisourcebergen Drug Corp to supply pharmaceuticals and medical supplies to support the Department of Defense. The contract has an...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $10,987.05 contract is for the supply of LEQVIO 284 MG/1.5 ML syringes, a specialty pharmaceutical product, in support of military treatment programs and facilities. AmerisourceBergen Drug Corp serves as the prime contractor on this delivery order, which is...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a Delivery Order contract valued at $6,592.23 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the provision of the prescription drug LEQVIO 284 MG/1.5 ML SYRINGE 1.5ML, with a period of performance through July 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...